This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van Staveren, W. C.G. Articles by Maenhaut, C. Search for Related Content PubMed PubMed Citation Articles by van Staveren, W. C.G. Articles by Maenhaut, C.

Human Thyroid Tumor Cell Lines Derived from Different Tumor Types Present a Common Dedifferentiated Phenotype

¹ Institute of Interdisciplinary Research (IRIBHM); ² Artificial Intelligence Laboratory (IRIDIA-CoDE); ³ Cytogenetics Laboratory, Medical Genetics Department, Erasme Hospital; ⁴ Department of Surgery, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium; ⁵ Service d'Anatomie et de Cytologie Pathologiques, Hôpital A. Paré (AP-HP), Université de Versailles, St. Quentin en Yvelines, France; and ⁶ South West Wales Cancer Institute/Swansea Clinical School, Singleton Hospital, Swansea, United Kingdom

Requests for reprints: Carine Maenhaut, Institute of Interdisciplinary Research (IRIBHM), 808 Route de Lennik, B-1070 Brussels, Belgium. Phone: 32-2-555-41-37; Fax: 32-2-555-46-55; E-mail: cmaenhau{at}ulb.ac.be.

Cell lines are crucial to elucidate mechanisms of tumorigenesis and serve as tools for cancer treatment screenings. Therefore, careful validation of whether these models have conserved properties of in vivo tumors is highly important. Thyrocyte-derived tumors are very interesting for cancer biology studies because from one cell type, at least five histologically characterized different benign and malignant tumor types can arise. To investigate whether thyroid tumor–derived cell lines are representative in vitro models, characteristics of eight of those cell lines were investigated with microarrays, differentiation markers, and karyotyping. Our results indicate that these cell lines derived from differentiated and undifferentiated tumor types have evolved in vitro into similar phenotypes with gene expression profiles the closest to in vivo undifferentiated tumors. Accordingly, the absence of expression of most thyrocyte-specific genes, the nonresponsiveness to thyrotropin, as well as their large number of chromosomal abnormalities, suggest that these cell lines have acquired characteristics of fully dedifferentiated cells. They represent the outcome of an adaptation and evolution in vitro, which questions the reliability of these cell lines as models for differentiated tumors. However, they may represent useful models for undifferentiated cancers, and by their comparison with differentiated cells, can help to define the genes involved in the differentiation/dedifferentiation process. The use of any cell line as a model for a cancer therefore requires prior careful and thorough validation for the investigated property. [Cancer Res 2007;67(17):8113–20]

This article has been cited by other articles:

				G. Perot, J. Derre, J.-M. Coindre, F. Tirode, C. Lucchesi, O. Mariani, L. Gibault, L. Guillou, P. Terrier, and A. Aurias Strong Smooth Muscle Differentiation Is Dependent on Myocardin Gene Amplification in Most Human Retroperitoneal Leiomyosarcomas Cancer Res., March 15, 2009; 69(6): 2269 - 2278. [Abstract] [Full Text] [PDF]

				M. D. Ringel "Thyroid Cancer" Cell Line Misidentification: A Time for Proactive Change J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4226 - 4227. [Full Text] [PDF]

				R. E. Schweppe, J. P. Klopper, C. Korch, U. Pugazhenthi, M. Benezra, J. A. Knauf, J. A. Fagin, L. A. Marlow, J. A. Copland, R. C. Smallridge, et al. Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4331 - 4341. [Abstract] [Full Text] [PDF]

				P. Pallante, A. Federico, M. T. Berlingieri, M. Bianco, A. Ferraro, F. Forzati, A. Iaccarino, M. Russo, G. M. Pierantoni, V. Leone, et al. Loss of the CBX7 Gene Expression Correlates with a Highly Malignant Phenotype in Thyroid Cancer Cancer Res., August 15, 2008; 68(16): 6770 - 6778. [Abstract] [Full Text] [PDF]